American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

January 01, 2016

Newsletter Sponsor

Increasing Supply Chain Efficiency

As clinical trials expand globally, the need for a worldwide infrastructure that can deliver pharmaceuticals intact and on time is more urgent than ever. It takes AmerisourceBergen to provide solutions that increase supply chain efficiency and secure investments in emerging markets.

	Industry News

ANI Pharmaceuticals Launches Flecainide Tablets

Mylan Launches Generic Zyvox® Tablets

Anika Therapeutics Enrolls First Patient in Phase III HYALOFAST® Study

FDA Accepts Epizyme’s IND Application for Tazemetostat

Dr. Reddy’s Relaunches Esomeprazole Magnesium Delayed-Release Capsules

Braeburn Pharmaceuticals and Camurus Enroll First Patient in a Phase III Efficacy Trial of Long-Acting Treatment for Opioid Dependence

	Featured Articles

Utilization of Automation to Enhance and Facilitate Development of a Mini-Tablet Formulation Utilization of Automation to Enhance and Facilitate Development of a Mini-Tablet Formulation Drug products for pediatric patients are typically formulated as powder for suspension, oral ... read more »

Recent Innovations in Pharmaceutical Hot Melt Extrusion Recent Innovations in Pharmaceutical Hot Melt Extrusion The importance of hot melt extrusion (HME) technology in the pharmaceutical industry is evident in ... read more »

	Featured Video

Shimadzu Partners with Hanson Research for Innovation in Dissolution Testing
Shimadzu Partners with Hanson Research for Innovation in Dissolution Testing
In this video, Mike Auerbach speaks with Keith Hamman, the President of Hanson Research, at AAPS 2015 about Hanson’s new partnership with Shimadzu. ... read more »

Interview with Shimadzu Corporation at AAPS 2015
Interview with Shimadzu Corporation at AAPS 2015
In this video filmed at AAPS 2015, Mike Auerbach speaks with Brian Domanski, Shimadzu’s Product Manager for HPLC, about Shimadzu’s newest technology. ... read more »

	Featured Whitepaper

Development of orally disintegrating tablets comprising controlled-release multiparticulate beads
Development of orally disintegrating tablets comprising controlled-release multiparticulate beads
Melperone is an atypical antipsychotic agent that has shown a wide spectrum of neuroleptic properties, particularly effective in the treatment of senile dementia and Parkinson’s-associated psychosis, ... read more »

Planning the execution of a viral clearance study
Planning the execution of a viral clearance study
It is important to get a viral clearance study done right the first time in order to avoid costly delays. Knowing the right questions to ask and establishing a detailed plan with close communication ... read more »

	Events


6th Annual Pharmacovigilance & Risk Management Strategies		Targeted Drug Delivery

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA